2020 is a milestone year for Zenith in its creation of watches tailored exclusively for women. Never afraid to adopt colours rarely explored in watchmaking, Zenith has created its most flamboyantly feminine watch to date, the DEFY 21 Pink Edition featuring the world’s first pink-treated movement. In association with Pink Ribbon Switzerland, Zenith commits to supporting a cause that affects countless women around the world.
Fitting of the DEFY 21’s lightning-fast 1/100th of a second chronograph movement and edgy design, Zenith has created for the first time ever in a mechanical watch an astonishingly pink PVD treated movement in the DEFY 21 Pink Edition, which is sure to make an audacious statement. Its rose gold case with sharp facets exudes out a different kind of brilliance, with 288 white diamonds of varying sizes perfectly set into the case. The rose gold bezel adds another layer of vivid sparkle, with 44 scintillating baguette-cut pink sapphire stones. Echoing the dashing tones of the watch’s exterior, the open black and golden dial reveals the striking metallic pink treated movement, which extends from the dial side right through to the star-shaped oscillating rotor on the back.
Recognizing the need to spread positivity and hope to countless women around the world who are battling breast cancer, pink takes on another meaning with the DEFY 21 Pink Edition. The Pink Ribbon is the international symbol for those who have been affected by the indiscriminate disease, helping to spread awareness and support for those who need it.
Zenith is proud to announce that it will be joining the global Pink Ribbon awareness movement, where a portion of the proceeds from the sale of the DEFY 21 Pink Edition will be donated to Pink Ribbon Switzerland. Zenith will also take part in the 10th Anniversary Pink Ribbon Switzerland Music Gala as an auction partner, to be held on 26th September at the Dolder Grand in Zurich. To lend its support and help raise funds, Zenith will offer a unique execution of this watch, the DEFY 21 “Pink Ribbon” edition, for the charity auction, where all proceeds from the auction sale will finance the VISION I project of SAKK (The Swiss Group for Clinical Cancer Research), a non-profit organization which has been conducting clinical trials in oncology since 1965 and promises to provide breast cancer patients gentler and better care.